Neurological disorders are mostly chronic, long-term conditions. Those affected may be at increased risk from Covid-19. However, as this strain of the coronavirus is new, the knowledge on how this will affect people with neurological disorders is still limited.
Based on evidence to date, we can assume that those with such underlying disorders may be more at risk from not only the virus directly, but also by being exposed to disruptions in healthcare provision. There are also concerns around emerging neurological complications from the disease and the slowing pace and prioritisation of neuroscience research.
In a statement recently published, the European Federation of Neurological Associations [EFNA] explores these challenges, as well as looking at the role of neurological patient organisations during and after this crisis.
Read the statement here:
https://www.efna.net/wp-content/uploads/2020/04/COVID-19_EFNA-message.pdf
EFNA has also created a COVID-19 resource hub for neurology patients/patient organisations which includes neurology disease-specific information, as well as general information from trusted health authorities such as EAN’s EANcore CoVID-19.
Visit the resource hub here: https://www.efna.net/covid-19/
